Literature DB >> 21570263

The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder.

C Y Yim1, J K Soczynska, S H Kennedy, H O Woldeyohannes, E Brietzke, R S McIntyre.   

Abstract

BACKGROUND: Persistent impairment in cognitive function has been described in euthymic individuals with bipolar disorder. Collective work indicates that obesity is associated with reduced cognitive function in otherwise healthy individuals. This sub-group post-hoc analysis preliminarily explores and examines the association between overweight/obesity and cognitive function in euthymic individuals with bipolar disorder.
METHODS: Euthymic adults with DSM-IV-TR-defined bipolar I or II disorder were enrolled. Subjects included in this post-hoc analysis (n=67) were divided into two groups (normal weight, body mass index [BMI] of 18.5-24.9 kg/m2; overweight/obese, BMI ≥ 25.0 kg/m2). Demographic and clinical information were obtained at screening. At baseline, study participants completed a comprehensive cognitive battery to assess premorbid IQ, verbal learning and memory, attention and psychomotor processing speed, executive function, general intellectual abilities, recollection and habit memory, as well as self-perceptions of cognitive failures.
RESULTS: BMI was negatively correlated with attention and psychomotor processing speed as measured by the Digit Symbol Substitution Test (P<0.01). Overweight and obese bipolar individuals had a significantly lower score on the verbal fluency test when compared to normal weight subjects (P<0.05). For all other measures of cognitive function, non-significant trends suggesting a negative association with BMI were observed, with the exception of measures of executive function (i.e., trail making test B) and recollection memory (i.e., process-dissociation task).
CONCLUSION: Notwithstanding the post-hoc methodology and relatively small sample size, the results of this study suggest a possible negative effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Taken together, these data provide the impetus for more rigorous evaluation of the mediational role of overweight/obesity (and other medical co-morbidity) on cognitive function in psychiatric populations.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21570263     DOI: 10.1016/j.eurpsy.2011.02.004

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  25 in total

1.  Differential Impact of Obesity on CD69 Expression in Individuals with Bipolar Disorder and Healthy Controls.

Authors:  Ana S Yamagata; Lucas B Rizzo; Raphael O Cerqueira; Janine Scott; Quirino Cordeiro; Roger S McIntyre; Rodrigo B Mansur; Elisa Brietzke
Journal:  Mol Neuropsychiatry       Date:  2018-02-01

2.  Body fat distribution and associations with metabolic and clinical characteristics in bipolar individuals.

Authors:  Nina Lackner; Harald Mangge; Eva Z Reininghaus; Roger S McIntyre; Susanne A Bengesser; Armin Birner; Bernd Reininghaus; Hans-Peter Kapfhammer; Sandra J Wallner-Liebmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-08       Impact factor: 5.270

3.  Clinical phenotype of bipolar disorder with comorbid binge eating disorder.

Authors:  Susan L McElroy; Scott Crow; Joanna M Biernacka; Stacey Winham; Jennifer Geske; Alfredo B Cuellar Barboza; Miguel L Prieto; Mohit Chauhan; Lisa R Seymour; Nicole Mori; Mark A Frye
Journal:  J Affect Disord       Date:  2013-06-03       Impact factor: 4.839

4.  Neurocognitive functioning in overweight and obese patients with bipolar disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

Authors:  Leonardo E Silveira; Jan-Marie Kozicky; Kesavan Muralidharan; Joana Bücker; Ivan J Torres; David J Bond; Flavio Kapczinski; Marcia Kauer-Sant'Anna; Raymond W Lam; Lakshmi N Yatham
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

5.  Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Authors:  S L McElroy; D E Kemp; E S Friedman; N A Reilly-Harrington; L G Sylvia; J R Calabrese; D J Rabideau; T A Ketter; M E Thase; V Singh; M Tohen; C L Bowden; E E Bernstein; B D Brody; T Deckersbach; J H Kocsis; G Kinrys; W V Bobo; M Kamali; M G McInnis; A C Leon; S Faraone; A A Nierenberg; R C Shelton
Journal:  Acta Psychiatr Scand       Date:  2015-06-26       Impact factor: 6.392

6.  Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder.

Authors:  M Strassnig; D Cornacchio; P D Harvey; R Kotov; L Fochtmann; E J Bromet
Journal:  J Psychiatr Res       Date:  2017-07-18       Impact factor: 4.791

Review 7.  Obesity in bipolar disorder: an overview.

Authors:  Susan L McElroy; Paul E Keck
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

8.  Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia.

Authors:  Colin A Depp; Martin Strassnig; Brent T Mausbach; Christopher R Bowie; Paula Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Ann E Pulver; Thomas L Patterson; Philip D Harvey
Journal:  Bipolar Disord       Date:  2014-04-12       Impact factor: 6.744

Review 9.  Diabetes mellitus and disturbances in brain connectivity: a bidirectional relationship?

Authors:  Rodrigo B Mansur; Danielle S Cha; Hanna O Woldeyohannes; Joanna K Soczynska; Andre Zugman; Elisa Brietzke; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2014-06-29       Impact factor: 3.843

10.  Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin.

Authors:  Rodrigo B Mansur; Francheska Delgado-Peraza; Mehala Subramaniapillai; Yena Lee; Michelle Iacobucci; Flora Nasri; Nelson Rodrigues; Joshua D Rosenblat; Elisa Brietzke; Victoria E Cosgrove; Nicole E Kramer; Trisha Suppes; Charles L Raison; Andrea Fagiolini; Natalie Rasgon; Sahil Chawla; Carlos Nogueras-Ortiz; Dimitrios Kapogiannis; Roger S McIntyre
Journal:  J Psychiatr Res       Date:  2020-12-04       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.